The top 20 enriched pathways in the FPQYLQYPY-treated group and the Ang II-treated group are presented in Figure 8 and were involved in diabetic cardiomyopathy, dilated cardiomyopathy, hypertrophic cardiomyopathy, regulation of actin cytoskeleton, cardiac muscle contraction, MAPK signaling pathway, and vascular smooth muscle contraction. The gene discussed is AGT; the disease is dilated cardiomyopathy.